Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Blood cancers, Cell type, Hodgkin lymphoma, Lymphoma
Closed
Phase 3
This trial is looking at a new drug called MK-4280A for Hodgkin lymphoma. It is open to people with a type of Hodgkin lymphoma called classical Hodgkin lymphoma that has:
come back after treatment or got worse during treatment
and there are no further treatment options available
Recruitment start: 30 December 2022
Recruitment end: 1 December 2024
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Graham Collins
Merck Sharp & Dohme LLC
Last reviewed: 21 May 2025
CRUK internal database number: 18701
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
